FORT LEE, N.J.--(BUSINESS WIRE)--Neurologix, Inc. (OTCBB: NRGX), a biotech company engaged in the development of innovative gene therapies for the brain and central nervous system, today announced that John E. Mordock, president and chief executive officer of the Company, will present at the Wall Street Reporter’s Small-Cap Discovery Conference in New York City.
